SCHEMBL29570949

SCHEMBL29570949

CCOC(=O)c1cnccc1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
TSHR P16473 1/20 0.53
TP53 P04637 1/20 0.48
CASP1 P29466 1/20 0.48
CDC7 O00311 2/20 0.48
DBF4 Q9UBU7 2/20 0.48
NUDT1 P36639 1/20 0.48
MMP13 P45452 1/20 0.47
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM5A P29375 1/20 0.46
KDM5B Q9UGL1 1/20 0.46
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL907851 1.00 SIRT3 (0.58) SIRT3TDP1TSHRTP53CASP1
Ethane SCHEMBL28930003 0.98 SIRT3 (0.56) SIRT3TDP1TSHRTP53CASP1
Iodomethane SCHEMBL10841815 0.97 SIRT3 (0.54) SIRT3TDP1TSHRTP53CASP1
SCHEMBL3515887 0.87 TSHR (0.60) SIRT3TDP1TSHRTP53CASP1
SCHEMBL29837473 0.87 TSHR (0.60) SIRT3TDP1TSHRTP53CASP1
SCHEMBL277304 0.86 TSHR (0.53) SIRT3TDP1TSHRTP53CASP1
SCHEMBL27703244 0.85 L3MBTL1 (0.58) SIRT3TDP1TSHRTP53ALDH1A1
SCHEMBL6640350 0.84 CA12 (0.56) TSHRTP53CASP1CDC7DBF4
SCHEMBL18149317 0.84 TSHR (0.52) SIRT3TDP1TSHRTP53CASP1
SCHEMBL3963549 0.83 ALDH1A1 (0.56) SIRT3TDP1TSHRTP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225447-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 EP disclosed
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed